Awaiting development: Guidance and quality standards
Showing 1 to 6 of 6
| Title | Type |
|---|---|
| Canagliflozin for treating type 2 diabetes in people 10 to 17 years TS ID 11888 | Technology appraisal guidance |
| Dulaglutide for treating type 2 diabetes [ID1451] | Technology appraisal guidance |
| LY3209590 for treating type 1 diabetes in people on multiple daily insulin injections [ID6498] | Technology appraisal guidance |
| LY3209590 for treating type 2 diabetes in people on daily insulin injections [ID6499] | Technology appraisal guidance |
| Semaglutide for treating type 2 diabetes (ID1450) | Technology appraisal guidance |
| Sotagliflozin for treating type 2 diabetes [ID1657] | Technology appraisal guidance |